Pharmacoeconomic assessment of the use of dalbavancin (xydalba) in the treatment of skin and soft tissue infections in hospital settings in the Russian Federation
2020 ◽
Vol 17
(4)
◽
pp. 83-87
2016 ◽
Vol 21
(4)
◽
pp. 219-225
Keyword(s):